List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 248 studies with search of: "Lopinavir/Ritonavir" [TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Lopinavir/Ritonavir (Kaletra)PK
Conditions: HIV/AIDS Treatment;   HIV Infections
Intervention: Drug: lopinavir/ritonavir (Kaletra®) tablets
2 Active, not recruiting Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva
Condition: HIV Infections
Interventions: Drug: Kaletra (lopinavir/ritonavir);   Drug: Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine)
3 Completed Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir
4 Terminated Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients
Conditions: HIV Infections;   Kaletra
Interventions: Drug: lopinavir/ritonavir;   Drug: lopinavir /ritonavir
5 Completed Dose Reduction of Lopinavir in Children
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir standard dose According to WHO simplified dosing table;   Drug: Lopinavir/ritonavir low dose ( 70% of WHO recommended dosing table)
6 Unknown † Pilot Assessment of Lopinavir/Ritonavir and Maraviroc
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention: Drug: lopinavir/ritonavir plus maraviroc
7 Completed Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients
Condition: HIV Infection
Interventions: Drug: lopinavir/ritonavir;   Drug: lamivudine/zidovudine
8 Completed Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)
Condition: HIV Infections
Interventions: Drug: Kaletra (lopinavir/ritonavir);   Drug: buprenorphine;   Other: Clinical evaluations/Blood draws
9 Active, not recruiting Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r
Conditions: HIV/HCV Co-infection;   HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Lopinavir/ritonavir with two nucleoside analogs
10 Active, not recruiting Comparison of Liquid Kaletra and Low Dose Kaletra Tablets
Condition: HIV Infections
Intervention: Drug: Low dose Kaletra tablets
11 Terminated GW873140 In Combination With Kaletra In HIV Infected Subjects
Conditions: Human Immunodeficiency Virus I Infection;   HIV Infection
Interventions: Drug: GW873140;   Drug: Kaletra (lopinavir/ritonavir)
12 Completed Lopinavir Capsules to Kaletra or Invirase Tablets
Condition: HIV Infections
Interventions: Drug: Saquinavir (Invirase®);   Drug: Lopinavir/ritonavir (Kaletra®)
13 Terminated Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV co-Infected Subjects vs Baseline Liver Biopsy Metavir Score
Condition: HIV Infection
Intervention: Drug: Lopinavir/Ritonavir
14 Completed Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients
Condition: HIV Infection
Interventions: Drug: Tenofovir DF;   Drug: lopinavir/ritonavir with 2 Nucleoside RTIs
15 Recruiting KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)
Condition: Antiretroviral Therapy in HIV-1 Infected Children
Interventions: Drug: Kaletra dosed once daily;   Drug: kaletra dosed twice daily
16 Completed
Has Results 		Metabolic Effects of Switching Kaletra to Boosted Reyataz
Condition: HIV Infections
Interventions: Drug: atazanavir/ritonavir;   Drug: lopinavir/ritonavir
17 Active, not recruiting Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Drug: efavirenz/emtricitabin/tenofovir;   Drug: lopinavir/ritonavir
18 Completed Kaletra-isentress Treatment Evaluation
Condition: HIV Infections
Intervention: Drug: Kaletra + Isentress
19 Recruiting Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)
Condition: HIV Infections
Intervention: Drug: lopinavir/ritonavir plus maraviroc
20 Active, not recruiting Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy
Conditions: HIV Infection;   Lipodystrophy;   HIV Infections
Interventions: Drug: Monotherapy (Lopinavir/ritonavir);   Drug: Monotherapy (Lopinavir/ritonavir) + ABC/3TC

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services